Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
British Journal of Haematology|June 10, 2025
Hyperdiploid myeloma: The silent majorityJ Erin Wiedmeier-Nutor, Rafael Fonseca
NPJ Precision Oncology|April 14, 2026
Proteomic profiling revealed unique disease biology associated with 1q abnormalities in multiple myelomaKiran K Mangalaparthi, Joel-Sean Hsu, J Erin Wiedmeier-Nutor, et al.
Cancers|July 13, 2024
Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number AlterationsJ Erin Wiedmeier-Nutor, Chantal E McCabe, Daniel R O'Brien, et al.
Blood Cancer Journal|February 5, 2025
Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic interventionRodrigo Fonseca, Yuan Xiao Zhu, Laura A Bruins, et al.
American Journal of Hematology|June 26, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple MyelomaKenneth J C Lim, Shaji Kumar, Ricardo Parrondo, et al.
Cancer|March 12, 2026
A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancerGayle S Jameson, Denise J Roe, Erkut Borazanci, et al.
Blood|June 10, 2025
Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myelomaBenjamin T Diamond, Linda B Baughn, Mansour Poorebrahim, et al.
Blood Cancer Journal|April 4, 2025
Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomesAbiola Bolarinwa, Madhu Nagaraj, Saurabh Zanwar, et al.
Pageof 1